Healthcare & Life Sciences
Hemotune
Germanyhemotune.ch
Hemotune is a Healthcare & Life Sciences startup based in Germany, most recent round Series B, 5 tracked investors.
Activeseries-b
series-b
Stage
5
Investors
About Hemotune
Hemotune is a company headquartered in Germany. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 5 investors associated with the company.
Hemotune develops an extracorporeal blood‑purification platform called HemoSystem that uses magnetic nanoparticles to selectively remove previously inaccessible biomolecules from blood. The technology is intended initially for treatment of uncontrolled immune reactions such as septic shock and may be applicable to other indications.
Explore Hemotune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.